These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8579763)

  • 1. Effect of RU-486 and related compounds on the proliferation of cultured macrophages.
    Roberts CP; Parthasarathy S; Gulati R; Horowitz I; Murphy AA
    Am J Reprod Immunol; 1995 Oct; 34(4):248-56. PubMed ID: 8579763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of monocyte to macrophage differentiation by antiglucocorticoids and antioxidants.
    Roberts CP; Murphy AA; Santanam N; Parthasarathy S
    Am J Obstet Gynecol; 1998 Aug; 179(2):354-62. PubMed ID: 9731838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of RU 486 and related compounds on cultured macrophage differentiation and function.
    Roberts CP; Murphy AA; Santanam N; Parthasarathy S
    Am J Obstet Gynecol; 1996 Aug; 175(2):248-57; discussion 257-9. PubMed ID: 8765239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiprogesterone and antiglucocorticoid actions of RU 486 on rabbit mammary gland explant cultures. Evidence for a persistent inhibitory action of residual progesterone upon the mammary tissue.
    Jahn GA; Houdebine LM; Djiane J
    J Steroid Biochem; 1987 Oct; 28(4):371-7. PubMed ID: 3669658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antiprogestin RU 486 on the proliferation and metabolic activity of stromal cells separated from human endometrium.
    Bhargava-Periwal S; Farooq A; Bhargava VL; Bhatla N; Vij U; Murugesan K
    Contraception; 1996 Feb; 53(2):127-31. PubMed ID: 8838491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-competitive anti-oestrogenic actions of progesterone antagonists in primate endometrium: enhancement of oestrogen and progesterone receptors with blockade of post-receptor proliferative mechanisms.
    Neulen J; Williams RF; Breckwoldt M; Chwalisz K; Baulieu EE; Hodgen GD
    Hum Reprod; 1996 Jul; 11(7):1533-7. PubMed ID: 8671500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progesterone induces the proliferation of urothelial cells in an epidermal growth factor dependent manner.
    Teng J; Wang ZY; Bjorling DE
    J Urol; 2003 Nov; 170(5):2014-8. PubMed ID: 14532844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RU486-induced growth inhibition of human endometrial cells.
    Murphy AA; Zhou MH; Malkapuram S; Santanam N; Parthasarathy S; Sidell N
    Fertil Steril; 2000 Nov; 74(5):1014-9. PubMed ID: 11056251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nongenomic uterine relaxing effect of RU 486 (mifepristone) prior to its antiprogesterone activity in the human pregnancy.
    Perusquía M; Espinoza J; Navarrete E
    Steroids; 2009 Oct; 74(10-11):825-31. PubMed ID: 19464306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New analogues of mifepristone with more dissociated antiprogesterone activities.
    Philibert D; Hardy M; Gaillard-Moguilewsky M; Nique F; Tournemine C; Nédélec L
    J Steroid Biochem; 1989; 34(1-6):413-7. PubMed ID: 2560520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigestogens.
    Baird DT
    Br Med Bull; 1993 Jan; 49(1):73-87. PubMed ID: 8324617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RU 486 (mifepristone). A short overview of its mechanisms of action and clinical uses at the end of 1996.
    Baulieu EE
    Ann N Y Acad Sci; 1997 Sep; 828():47-58. PubMed ID: 9329823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progesterone and dexamethasone inhibition of uterine epithelial cell proliferation: studies with antiprogesterone compounds in the neonatal mouse.
    Bigsby RM; Young PC
    J Steroid Biochem Mol Biol; 1993 Aug; 46(2):253-7. PubMed ID: 8664174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiprogestins and iatrogenic glucocorticoid resistance.
    Koper JW; Molijn GJ; van Uffelen CJ; Stigter E; Lamberts SW
    Life Sci; 1997; 60(9):617-24. PubMed ID: 9048964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone antagonists increase androgen receptor expression in the rhesus macaque and human endometrium.
    Slayden OD; Nayak NR; Burton KA; Chwalisz K; Cameron ST; Critchley HO; Baird DT; Brenner RM
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2668-79. PubMed ID: 11397870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tonic support of luteinizing hormone secretion by adrenal progesterone in the ovariectomized monkey replaced with midfollicular phase levels of estradiol.
    Xiao E; Xia-Zhang L; Shanen D; Ferin M
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2233-8. PubMed ID: 9215299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mifepristone: treatment of Cushing's syndrome.
    Sartor O; Cutler GB
    Clin Obstet Gynecol; 1996 Jun; 39(2):506-10. PubMed ID: 8734015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of RU 486 on immune function and steroid-induced immunosuppression in vitro.
    Van Voorhis BJ; Anderson DJ; Hill JA
    J Clin Endocrinol Metab; 1989 Dec; 69(6):1195-9. PubMed ID: 2584354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity of the progesterone antagonists ZK 98.299 and RU 38.486 in the hormone-dependent MXT mammary tumor model of the mouse and the DMBA- and the MNU-induced mammary tumor models of the rat.
    Schneider MR; Michna H; Nishino Y; el Etreby MF
    Eur J Cancer Clin Oncol; 1989 Apr; 25(4):691-701. PubMed ID: 2497018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivation.
    Bertagna X; Escourolle H; Pinquier JL; Coste J; Raux-Demay MC; Perles P; Silvestre L; Luton JP; Strauch G
    J Clin Endocrinol Metab; 1994 Feb; 78(2):375-80. PubMed ID: 8106625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.